We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Repligen Corp
23 own
9 watching
Current Price
$193.85
$1.83
(0.95%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
10,762.48M
52-Week High
262.26
52-Week Low
137.21
Average Volume
0.3M
Dividend Yield
--
P/E Ratio
128.7606
Market Capitalization10,762.48M52-Week High262.2652-Week Low137.21Average Volume0.3MDividend Yield--P/E Ratio128.7606What does the Repligen Corp do?
Repligen Corporation, a bioprocessing company, focuses on the development, production, and commercialization of products used in the production of antibody-based therapeutics, recombinant proteins, and vaccines worldwide. It manufactures various forms of Protein A, a critical component used to purify antibody-based drugs. The company also supplies alternating tangential flow system filtration devices and protein cell culture supplements that are used in clinical and commercial stage manufacturing to enhance biologic drug yields. In addition, it manufactures and sells OPUS pre-packed chromatography columns, which are used in the purification of clinical-stage biologics; and tangential flow filtration cassettes that are used to concentrate clinical and commercial stage biologic drugs. Further, the company has a portfolio of therapeutic product candidates, which include histone deacetylase inhibitor for the treatment of Friedreich's ataxia disease; and RG1068, a synthetic human hormone developed as a novel imaging agent for the detection of pancreatic duct abnormalities in combination with magnetic resonance imaging in patients with pancreatitis and other pancreatic diseases. The company sells its bioprocessing products directly and through distributors to various life sciences companies, biopharmaceutical companies, and contract manufacturers. Repligen Corporation was founded in 1981 and is headquartered in Waltham, Massachusetts.
Read More
How much money does Repligen Corp make?
News & Events about Repligen Corp.
Zolmax
1month ago
Repligen (NASDAQ:RGEN Get Rating) had its price objective lowered by investment analysts at SVB Leerink from $230.00 to $200.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has an outperform rating on the biotechnology companys stock. SVB ...
Globe Newswire
1month ago
WALTHAM, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at the 41stAnnual J.P. Morgan Healthcare conference being held January 9-12 in San Francisco. Tony J. ...
Zolmax
2 months ago
Royal Bank of Canada started coverage on shares of Repligen (NASDAQ:RGEN Get Rating) in a research report report published on Tuesday, The Fly reports. The firm issued a sector perform rating and a $190.00 price target on the biotechnology companys stock. RGEN has been the topic of ...
Zolmax
2 months ago
Repligen Co. (NASDAQ:RGEN Get Rating) CEO Anthony Hunt sold 25,000 shares of the businesss stock in a transaction dated Friday, November 11th. The stock was sold at an average price of $200.00, for a total transaction of $5,000,000.00. Following the sale, the chief executive officer now directly ...
PR Newswire
4 months ago
Thinking about trading options or stock in Laredo Petroleum, Repligen, Tesla, Amazon, or Advanced Micro Devices? Thinking about trading options or stock in Laredo Petroleum, Repligen, Tesla, Amazon, or Advanced Micro Devices? PR Newswire NEW YORK, Oct. 4, 2022 NEW YORK, Oct. 4, 2022 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Repligen Corp share price today?
Can Indians buy Repligen Corp shares?
How can I buy Repligen Corp shares from India?
Can Fractional shares of Repligen Corp be purchased?
What are the documents required to start investing in Repligen Corp stocks?
What is today’s traded volume of Repligen Corp?
What is today’s market capitalisation of Repligen Corp?
What is the 52-Week High and Low Range of Repligen Corp?
What percentage is Repligen Corp down from its 52-Week High?
What percentage is Repligen Corp up from its 52-Week Low?
Current Price
$193.85
$1.83
(0.95%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.